InvestorsHub Logo
Followers 18
Posts 1365
Boards Moderated 0
Alias Born 12/30/2013

Re: None

Monday, 06/02/2014 11:15:25 AM

Monday, June 02, 2014 11:15:25 AM

Post# of 140476
Point of Returns SA report on TITXF was quit biased to TITXF obviously, but sad to see such presence of misinformation in that article on TRXC. Clearly just trying to bash it, Point did you miss the memo that TRXC's SurgiBot will cost $300,000 less than TITXFs SPORT at $500,000 compared to $800,000 for the sport. that's a big difference.

How about the fact that TRXCs SurgiBot has 100% TRUE tactile feedback compared to zero tactile feedback for TITXF Sport.

How about the fact that TRXC's SUrgibot will begin sales in Q3 of 2015, while TITXF will just be submittin their FDA paper work in second half of 2015. That means TITXF won't be generating any revenue or begin commercialization of machine until atleast Q2 of 2016. Gives nice headstart to TRXC.

Also, because the surgeon stands its a worse designed machine? WhAT?? haha....this is gonna be a long ride, and very fun, but man oh man what a lack of info in that one.

I recall asking Dr. Hargove in my interview with him about tele surgery and let me tell you he said that was far far far in the future. Silly to it being infered that it will be coming soon.

Material information that should have been included and shared with everyone. Sad to see this missing from report, more due dilligence is required.